(Total Views: 666)
Posted On: 08/25/2020 12:52:54 PM
Post# of 149413
The m/m trials did not break out deaths.
M/m without expectation of death.
Also 84 patients rather than 10s of thousands with convalescent plasma.
64% fewer SAES in the leronlimab group (which if we "did a Hahn" and noted that none of the SAEs were attributed to Leronlimab by the investigators), would be a 100% reduction.
M/m without expectation of death.
Also 84 patients rather than 10s of thousands with convalescent plasma.
64% fewer SAES in the leronlimab group (which if we "did a Hahn" and noted that none of the SAEs were attributed to Leronlimab by the investigators), would be a 100% reduction.
(5)
(0)Scroll down for more posts ▼
